Skip to main content
SpringerLink
Log in

Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins

  • Pharmacokinetics and Disposition
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

The pharmacokinetics of lorazepam was examined in 10 male patients with insulin-dependent diabetes mellitus before and following treatment with neomycin and cholestyramine. Neomycin and cholestyramine were given in an attempt to block the enterohepatic circulation of lorazepam and so to permit an in vivo estimate of hepatic glucuronidation. The volume of distribution and clearance of free lorazepam in diabetic patients were not significantly different from the corresponding estimates in 14 normal controls. Neomycin and cholestyramine increased the clearance of lorazepam by 63% consistent with their effect in non-diabetic controls. However, patients on beef/pork insulin exhibited a greater than normal increase on this interupting regimen (125%), and had a significantly greater neomycin/cholestyramine cycling-interrupted clearance of lorazepam than either normal controls or patients on human insulin (15.4 vs. 6.96 and 7.87 ml·min−1·kg−1). The clearance was correlated positively and significantly with HbA1c and glycated proteins (fructosamine), but only in patients on human insulin. Thus, the pharmacokinetics of lorazepam was not altered in patients with insulin-dependent diabetes mellitus. However, it is possible that there are differences in the rate and extent of hepatic glucuronidation and enterohepatic circulation of lorazepam between patients treated with beef/pork and human insulins and between diabetics treated with beef/pork insulin and non-diabetic controls.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hinohara Y, Takanashi S, Nagashima R, Shioya A (1974) Glucuronic acid pathway in alloxan diabetic rabbits. I. Urinary excretion of metabolites related to the glucuronic acid pathway. Jap J Pharmacol 24:869–878

    Google Scholar 

  2. Sochor M, Baquer NZ, McLean P (1979) Regulation of pathways of glucose metabolism in kidney. The effect of experimental diabetes on the activity of the pentose phosphate pathway and the glucuronate-xylulose pathway. Arch Biochem Biophys 198:632–646

    Google Scholar 

  3. Sochor M, Kunjara S, Greenbaum AL, McLean P (1986) Renal hypertrophy in experimental diabetes. Effect of diabetes on the pathways of glucose metabolism: differential response in adult and immature rats. Biochem J 234:573–577

    Google Scholar 

  4. Dajani RM, Kayyali SY (1973) The biotransformation of acetophenetidin in the alloxan-diabetic rabbit. Comp Gen Pharmacol 4:23–35

    Google Scholar 

  5. Eacho PI, Sweeny D, Weiner M (1981) Conjugation of p-nitroanisole and p-nitrophenol in hepatocytes isolated from streptozotocin diabetic rats. J Pharmacol Exp Ther 218:34–40

    Google Scholar 

  6. Price VF, Jollow DJ (1982) Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity. J Pharmacol Exp Ther 220:504–513

    Google Scholar 

  7. Morrison MH, Hawksworth GM (1984) Glucuronic acid conjugation by hepatic microsomal fractions isolated from streptozotocin-induced diabetic rats. Biochem Pharmacol 33:3833–3838

    Google Scholar 

  8. Morrison MH, Barber HE, Foschi PG, Hawksworth GM (1986) The kinetics of 4-nitrophenol conjugation by perfused livers and hepatic microsomes from streptozotocin induced diabetic rats. J Pharm Pharmacol 38:188–194

    Google Scholar 

  9. Vega P, Gaule C, Sanchez E, del Villar E (1986) Inhibition and activation of UDP-glucuronyltransferase in alloxan diabetic rat. Gen Pharmacol 17:641–645

    Google Scholar 

  10. Watkins JB, Dykstra TP (1987) Alterations in biliary excretion function by streptozotocin-induced diabetes. Drug Metab Dispos 15:177–183

    Google Scholar 

  11. Daintith H, Stevenson IH, O'Malley K (1976) Influence of diabetes mellitus on drug metabolism in man. Int J Clin Pharmacol Biopharm 13:55–58

    Google Scholar 

  12. Murali KV, Adithan C, Shashindran CH, Gambhir SS, Chandrasekar S (1983) Antipyrine metabolism in patients with diabetes mellitus. Clin Exp Pharmacol Physiol 10:7–13

    Google Scholar 

  13. Ruiz-Cabello F, Erill S (1984) Abnormal serum protein binding of acidic drugs in diabetes mellitus. Clin Pharmacol Ther 36:691–695

    Google Scholar 

  14. Zysset T, Wietholtz H (1988) Differential effect of type I and type II diabetes on antipyrine disposition in man. Eur J Clin Pharmacol 34:369–375

    Google Scholar 

  15. Adithan C, Danda D, Swaminathan RP, Indhiresan J, Shashindran CH, Bapna JS, Chandrasekar S (1988) Effect of diabetes mellitus on salivary paracetamol elimination. Clin Exp Pharmacol Physiol 15:465–471

    Google Scholar 

  16. Adithan C, Sriram G, Swaminathan RP, Krishnan M, Bapna JS, Chandrasekar S (1989) Effect of type II diabetes mellitus on theophylline elimination. Int J Clin Pharmacol 27:258–260

    Google Scholar 

  17. Gitanjali B, Adithan C, Raveendran R, Shashindran CH, Chandrasekar S (1992) Pharmacokinetics of single dose oral digoxin in patients with uncomplicated type II diabetes mellitus. Int J Clin Pharmacol 30:113–116

    Google Scholar 

  18. Greenblatt DJ, Schillings RT, Kyriakopoulos AA, Shader RI, Sisenwine SF, Knowles JA, Ruelius HW (1976) Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14-C lorazepam. Clin Pharmacol Ther 20:329–341

    Google Scholar 

  19. Ruelius HW (1978) Comparative metabolism of lorazepam in man and four animal species. J Clin Psychiatry 39:11–15

    Google Scholar 

  20. Wilkinson GR, Shand DG (1975) A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18:377–390

    Google Scholar 

  21. Crom WR, Webster SL, Bobo L, Teresi ME, Relling MV, Evans WE (1987) Simultaneous administration of multiple model substrates to assess hepatic drug clearance. Clin Pharmacol Ther 41:645–650

    Google Scholar 

  22. Herman RJ, Van Pham JD, Szakacs CBN (1989) Disposition of lorazepam in human beings: enterohepatic recirculation and first-pass effect. Clin Pharmacol Ther 46:18–25

    Google Scholar 

  23. Chaudhary A, Lane RA, Woo D, Herman RJ (1993) Multipledose lorazepam kinetics:shuttling of lorazepam glucuronide between the circulation and the gut during day-time and nighttime dosing intervals in response to feeding. J Pharmacol Exp Ther 267:1034–1038

    Google Scholar 

  24. Herman RJ, Chaudhary A, Szakacs CBN (1994) Disposition of lorazepam in Gilbert's syndrome: effects of fasting, feeding and enterohepatic circulation. J Clin Pharmacol 34:978–984

    Google Scholar 

  25. Tozer TN, Gambertoglio JG, Furst DE, Avery DS, Holford HG (1983) Volume shifts and binding estimates using equilibrium dialysis: application to prednisolone binding in humans. J Pharm Sci 72:1442–1446

    Google Scholar 

  26. Yamaoka K, Nakagawa T, Uno T (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equation. J Pharmacokinet Biopharm 6:165–175

    CAS  PubMed  Google Scholar 

  27. Boxenbaum HG, Riegelman S, Elashoff RM (1974) Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm 2:123–148

    Google Scholar 

  28. Yeh KC, Kwan KC (1978) A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximations. J Pharmacokinet Biopharm 6:79–98

    CAS  PubMed  Google Scholar 

  29. Gibaldi M, Perrier D (1982) Noncompartmental analysis based on statistical moment theory. In: Gibaldi M, Perrier D (eds) Pharmacokinetics. Dekker, New York, pp 409–417

    Google Scholar 

  30. Narango CA, Sellers EM, Giles HG, Abel JG (1980) Diurnal variations in plasma diazepam concentrations associated with reciprocal changes in free fraction. Br J Clin Pharmacol 9:265–272

    Google Scholar 

  31. Sjobom NC, Lins PE, Adamson U, Theodorsson E (1990) A comparative study on the hormonal responses to insulin-induced hypoglycemia using semisynthetic human insulin and pork insulin in patients with type 1 diabetes mellitus. Diabetic Med 7:775–779

    Google Scholar 

  32. Tattersall RB, Gill GV (1991) Unexplained deaths of type-I diabetic patients. Diabetic Med 8:49–58

    Google Scholar 

  33. Dahlan AA, Vrbancic MI, Hogan TE, Woo D, Herman RJ (1993) Greater sedative response to lorazepam in patients with insulin-dependent diabetes mellitus while on treatment with beef/pork versus human insulin. Clin Invest Med 16:18B

    Google Scholar 

  34. Kern W, Schlosser C, Kerner W, Pietrowsky R, Born J, Fehm HL (1994) Evidence for effects of insulin on sensory processing in humans. Diabetes 43:351–356

    Google Scholar 

  35. King GL, Kahn CR (1981) Non-parallel evolution of metabolic and growth-promoting functions of insulin. Nature 292:644–646

    Google Scholar 

  36. Kahn CR, Shechter Y (1990) Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics. Permagon, Toronto, pp 1463–1495

    Google Scholar 

  37. Sesti G, Marini MA, Montemurro A, Borboni P, Di Cola G, Bertoli A, De Pirro R, Lauro R (1991) Evidence that human and porcine insulin differently affect the human insulin receptor: studies with monoclonal anti-insulin receptor antibodies. J Endocrinol Invest 14:913–918

    Google Scholar 

  38. Mosthaf L, Grako K, Dull TJ, Coussens L, Ullrich A, McClain DA (1990) Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO 9:2409–2413

    Google Scholar 

  39. Rosenzweig A, Zetterstrom C, Benjamin A (1990) Identification of retinal insulin receptors using site-specific antibodies to a carboxy-terminal peptide of the human receptor alpha-subunit. Up-regulation of neuronal insulin receptors in diabetes. J Biol Chem 265:18030–18034

    Google Scholar 

  40. Olefsky JM (1990) The insulin receptor. A multifunctional protein. Diabetes 39:1009–1016

    Google Scholar 

  41. McClain DA, Maegawa H, Thies RS, Olefsky JM (1990) Dissection of the growth versus metabolic effects of insulin and insulin-like growth factor-I in transfected cells expressing kinase-defective human insulin receptors. J Biol Chem 265:1678–1682

    Google Scholar 

  42. Takata Y, Webster NJ, Olefsky JM (1991) Mutation of the two carboxy-terminal tyrosines results in an insulin receptor with normal metabolic signaling but enhanced mitogenic signaling properties. J Biol Chem 266:9135–9139

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine and Pharmacology, Royal University Hospital, University of Saskatchewan, S7N OWO, Saskatoon, Saskatchewan, Canada

    R. J. Herman, A. Chaudhary, C. B. Szakacs, D. Woo, R. Lane & M. A. Boctor

Authors
  1. R. J. Herman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Chaudhary
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. B. Szakacs
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Woo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Lane
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. A. Boctor
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herman, R.J., Chaudhary, A., Szakacs, C.B. et al. Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins. Eur J Clin Pharmacol 48, 253–258 (1995). https://doi.org/10.1007/BF00198307

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00198307

Key words

Search

Navigation